Lincoln Pharmaceuticals Dividende

Zukünftiges Wachstum Kriterienprüfungen 5/6

Lincoln Pharmaceuticals ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.23%, die durch die Erträge gut gedeckt ist.

Wichtige Informationen

0.3%

Dividendenausschüttung

4%

Ausschüttungsquote

Durchschnittlicher Branchenertrag0.6%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktie₹1.800
Gewinn pro Aktie₹48.91
Prognose der Dividendenrenditen/a

Aktuelle Dividendenentwicklung

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Sep 08
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Recent updates

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Sep 08
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be Increased To ₹1.80

Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?

Sep 06
Do Lincoln Pharmaceuticals' (NSE:LINCOLN) Earnings Warrant Your Attention?

Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Mar 14
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Nov 04
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 12
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

Aug 29
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Feb 14
If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Aug 16
Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

May 06
Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Apr 03
Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Mar 15
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Feb 28
Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Feb 12
Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Feb 01
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Jan 19
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Jan 06
Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Dec 27
Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Dec 14
Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Dec 01
Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Nov 18
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Nov 05
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: LINCOLNDie Dividende je Aktie war in den letzten 10 Jahren stabil.

Wachsende Dividende: LINCOLN Die Dividendenzahlungen des Unternehmens sind in den letzten 10 Jahren gestiegen.


Dividendenrendite im Vergleich zum Markt

Lincoln Pharmaceuticals Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von LINCOLN im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (LINCOLN)0.3%
Untere 25 % des Marktes (IN)0.2%
Markt Top 25 % (IN)1.0%
Branchendurchschnitt (Pharmaceuticals)0.6%
Analystenprognose (LINCOLN) (bis zu 3 Jahre)n/a

Bemerkenswerte Dividende: LINCOLNDie Dividende des Unternehmens (0.24%) ist höher als die der untersten 25% der Dividendenzahler auf dem Indian Markt (0.24%).

Hohe Dividende: LINCOLNDie Dividende des Unternehmens (0.26%) ist im Vergleich zu den besten 25 % der Dividendenzahler auf dem Markt Indian (1.2%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Mit ihrer niedrigen Ausschüttungsquote (3.7%) sind die Dividendenzahlungen von LINCOLN durch die Erträge vollständig gedeckt.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Mit seiner niedrigen Ausschüttungsquote (15.3%) sind die Dividendenzahlungen von LINCOLN gut durch den Cashflow gedeckt.


Entdecken Sie dividendenstarke Unternehmen